Abstract:
Introduction: The myopia epidemic has become a public health problem that cannot
be ignored. In 2010, 28% of the world's population suffered from myopia, and by
2050, this number could reach 50%.
Material and methods: We conducted a prospective, observational study of 19
patients aged 7 to 32 years who received treatment with orthokeratology lenses or
MiYOSMART lenses. Patients treated with orthokeratology lenses were followed up
from 2014-2023, and patients treated with MiYOSMART lenses from 2022-2024, at
Stereopsis Ophthalmologic Clinic, Iasi.
Results: In our study, female patients predominated (63%). 55% of patients treated
with the orthokeratology lens had low myopia, 35% medium myopia and 10%
myopic astigmatism. Corneal topography was performed with difficulty in 20% of
cases treated with orthokerathology lens. In patients treated with MiYOSMART
lenses, 33.33% achieved maximum visual acuity (VA=1).
Conclusion: As the prevalence of myopia continues to increase, these therapies
should be implemented to combat the vision deficits as well as the decreased quality
of life associated with myopia. Informing both children and parents about the
complications and treatment of myopia is particularly important. Moreover, the
introduction of national screening programs would be extremely beneficial for the
early diagnosis and treatment of this pathology. Keywords: myopia epidemic,
children, treatment.
